Crossmark

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease

Crossref DOI link: https://doi.org/10.1016/j.medine.2022.02.013

Published Print: 2022-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

González-Castro, A.

Cuenca Fito, E.

Fernandez, A.

Escudero Acha, P.

Rodríguez Borregán, J.C.

Peñasco, Y.
License Information

Text and Data Mining valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01
More Information

This article is maintained by: Elsevier

Article Title: Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease

Journal Title: Medicina Intensiva (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medine.2022.02.013

Content Type: simple-article

Copyright: © 2022 Published by Elsevier España, S.L.U.